Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/549
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOsei-Asare, Christina-
dc.contributor.authorOwusu, Fredrick William Akuffo-
dc.contributor.authorEntsie, Philomena-
dc.contributor.authorAnnan, Ama Kwansima-
dc.contributor.authorGyamaa, Rita Akosua-
dc.contributor.authorAmenuke, Edem Makafui-
dc.date.accessioned2024-05-02T17:00:12Z-
dc.date.available2024-05-02T17:00:12Z-
dc.date.issued2021-01-18-
dc.identifier.citationOsei-Asare, C., Owusu, F. W. A., Entsie, P., Annan, A. K., Gyamaa, R. A., & Amenuke, E. M. (2021). Formulation and in vitro evaluation of oral capsules from liquid herbal antimalarials marketed in Ghana. Journal of tropical medicine, 2021.en_US
dc.identifier.urihttps://doi.org/10.1155/2021/6694664-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/549-
dc.description.abstractMalaria ranks amongst the major health challenges faced by many developing countries. In Sub-Saharan and tropical regions of Africa, malaria continues to claim the life of one out of every twenty children below the age of five years. In adults, mortality rates are lower, but frequent debilitating attacks reduce the quality of life for chronic sufferers. ,e patronage and usage of liquid herbal antimalarials in the management and treatment of malaria in Ghana have been on the ascendency over the past decade. ,is project seeks to transform five liquid herbal antimalarial preparations (Agbeve pevah, Time mixture, Givers mixture, Masada mixture, and Rooter mixture) produced locally and commonly used for the treatment of malaria fever into capsules. ,is will help eliminate the current limitations, such as lack of patient compliance due to the bitterness and bulky nature of packaged preparation. ,e amount of dry extract per dose of each herbal antimalarial preparation and the wavelength of maximum absorption (λmax) of aqueous solutions of Agbeve, Time, Givers, Masada, and Rooter extract were determined. ,e flow properties of formulated granules were determined and subsequently encapsulated. ,e formulated capsules were evaluated using basic pharmacopeial tests, such as uniformity of weight, disintegration, drug content, and dissolution. Difference, f1, and similarity, f2, factors were employed in analyzing the dissolution profiles of the formulated capsules. ,e formulated granules exhibited good flow properties and passed the weight uniformity, disintegration, and drug content tests. ,e capsules exhibited optimal release of extract at the 45th minute in 0.1 M HCL. All formulated capsules had f 2 values >50 and f 1 values <15, indicating the similarity of their drug release profiles with their respective liquid herbal antimalarials. Oral capsules of Agbeve, Time, Givers, Masada, and Rooter have been successfully formulated and can be used as a substitute for Agbeve pevah, Time mixture, Givers mixture, Masada mixture, and Rooter mixture, respectively, in the treatment of malaria.en_US
dc.description.sponsorshipCopyright © 2021 Christina Osei-Asare et al. ,is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly citeden_US
dc.language.isoenen_US
dc.publisherJournal of tropical medicineen_US
dc.subjectIn vitro evaluationen_US
dc.subjectOral capsulesen_US
dc.subjectLiquid herbal antimalarialsen_US
dc.subjectGhanaen_US
dc.subjectMalariaen_US
dc.titleFormulation and in vitro evaluation of oral capsules from liquid herbal antimalarials marketed in Ghanaen_US
dc.typeArticleen_US
Appears in Collections:ARTICLES



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.